Library

| Expert Insight

4 minute read

Who’s going to pay for Covid-19 treatment?

The federal government has already passed legislation requiring private insurers, Medicare, Medicaid to cover testing for the novel coronavirus and coronavirus-related doctor visits without any cost to the patient. However, when it comes to the question of who’s going to pay for Covid-19 treatments, the answer is murky. For the majority of people who get Covid-19, symptoms are likely to be mild to moderate and can be treated by resting at home, but for those who require hospitalization, the costs could be very high.


The federal government has already passed legislation requiring private insurers, Medicare, and Medicaid to cover testing for the novel coronavirus and coronavirus-related doctor visits without any cost to the patient.

However, when it comes to the question of who’s going to pay for Covid-19 treatment, the answer is murky. For the majority of people who get Covid-19, symptoms are likely to be mild to moderate and can be treated by resting at home, but for those who require hospitalization, the costs could be very high.

Many large national plans, such as Cigna, Aetna, Humana, Centene, and United, as well as some Blues plans including Florida Blue, BCBS of Michigan, and BCBS of North Carolina, have already agreed to waive cost sharing for members’ Covid-19 treatment in their fully-funded and Medicare Advantage plans.

Read on for what the cost of coronavirus treatment could be and who will front the bill.  You can also jump to the section you are interested in: uninsured, Medicare, Medicaid, or commercial insurance.


SPONSORED BY

INTENDED AUDIENCE

AFTER YOU READ THIS

AUTHORS

Sally Kim

Director, Health plan research

TOPICS

INDUSTRY SECTORS

Don't miss out on the latest Advisory Board insights

Create your free account to access 1 resource, including the latest research and webinars.

Want access without creating an account?

   

You have 1 free members-only resource remaining this month.

1 free members-only resources remaining

1 free members-only resources remaining

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox

This content is available through your Curated Research partnership with Advisory Board. Click on ‘view this resource’ to read the full piece

Email ask@advisory.com to learn more

Click on ‘Become a Member’ to learn about the benefits of a Full-Access partnership with Advisory Board

Never miss out on the latest innovative health care content tailored to you. 

Benefits Include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox

This is for members only. Learn more.

Click on ‘Become a Member’ to learn about the benefits of a Full-Access partnership with Advisory Board

Never miss out on the latest innovative health care content tailored to you. 

Benefits Include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox
AB
Thank you! Your updates have been made successfully.
Oh no! There was a problem with your request.
Error in form submission. Please try again.